Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Consumer Defensive Food Distribution Cannabis Health Care
Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products. Mikra's products consists of Focus, Protect, Serenity, and CELLF.


TSXV:LFST - Post by User

Lifeist Wellness Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Post by steveM45on Feb 27, 2024 4:48pm
128 Views
Post# 35902455

More bad news....

More bad news....Lifeist also issued an aggregate of 4.8 million common shares and 1.2 million common share purchase warrants to acquire up to 1.2 million common shares as payment to Singular of the monthly fee of $20,000 for services provided in each of the months of October, November, and December 2023, calculated in accordance with the Consulting Agreement.

The common shares were issued at deemed prices per share ranging from $0.0108 to $0.015. The warrants have an exercise price of $0.05 per share and expire 5 years from their respective date of issuance.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities